CompoAtlas

EFIRUB Gommes

Food supplement declared in France, declaration No 2024-3-1632, decision dated 29 March 2024

EFIRUB Gommes is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
not provided
Food business operator placing the product on the market
LES TROIS CHENES
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Gomme
Daily dose
6 gommes
Not recommended for (according to the manufacturer)
Femmes allaitantes, Femmes enceintes
Objectives stated by the manufacturer (these are not authorised claims)
Voies respiratoires

Declaration 303159, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

None of the rules we check applies to the declared ingredients.

Declared composition

Plants

PlantPartPreparationPer day
Salvia officinalis L.FeuilleExtrait sec aqueux250 mg
Sisymbrium officinale (L) Scop.Parties aériennesExtrait sec aqueux168 mg
Zingiber officinale RoscoeRhizomeExtrait sec aqueux168 mg
Althaea officinalis L.RacineExtrait sec aqueux125 mg
Carica papaya L.FruitPoudre (de plantes séchées ou broyées)100 mg
Citrus paradisi Macfad.PépinExtrait sec hydroalcoolique51 mg

Additives

E420, E955, E414, E965, E903

Other ingredients

huile végétale, menthol

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging

Label warnings

Déconseillé avant l'âge de 6 ans. Une consommation excessive peut avoir des effets laxatifs.Déconseillé en cas de traitement médicamenteux concomitant contenant de la guimauve (60 minutes d'intervalle).

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

List recorded in 2024. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line